Prion diseases are a group of fatal neurodegenerative disorders caused by prions, which consist mainly of the abnormally folded isoform of prion protein, PrP Sc 
Consistently, sortilin-knockdown increased PrP
Sc accumulation in prion-infected cells. In 
Introduction
Prion diseases are a group of fatal neurodegenerative disorders, which include CreutzfeldtJakob disease in humans and bovine spongiform encephalopathy and scrapie in animals [1] . They are caused by the infectious agents termed prions, which mainly consist of the abnormally folded, amyloidogenic isoform of prion protein, designated PrP
Sc
. PrP Sc is a β-sheet-rich conformer produced by conformational conversion of the cellular counterpart, PrP C [1] . Intermolecular interaction between PrP C and PrP Sc is essential for the conversion of PrP C into PrP Sc . We and others have shown that mice devoid of PrP C neither developed the disease nor accumulated PrP Sc even after prions were inoculated into their brains [2] [3] [4] [5] . These results indicate that the conversion of PrP C into PrP Sc plays a pivotal role in the pathogenesis of prion disease, and that depletion of PrP C could be therapeutic by preventing the production of PrP Sc .
PrP
C is normally located at the cell surface as a glycosylphosphatidylinositol (GPI)-anchored glycoprotein [6] . Some endocytosed PrP C molecules are transported to lysosomes for degradation while others are recycled to the cell surface through the endocytic recycling compartments [7] . PrP Sc is also trafficked to lysosomes for degradation [7] . However, the cellular transport mechanism of PrP C and PrP Sc to lysosomes remains unknown. Whether prion infection or PrP Sc impairs the lysosomal trafficking of PrP C and PrP Sc for its progressive propagation is also unknown. The vacuolar protein sorting-10 protein (VPS10P)-domain receptors, including sortilin, SorLA, SorCS1, SorCS2 and SorCS3, are multi-ligand type I transmembrane proteins abundantly expressed in the brain and involved in neuronal function and viability [8, 9] . They function as a cargo receptor to deliver a number of cargo proteins to their subcellular destination through the VPS10P domain in the extracellular luminal N-terminus. Sortilin traffics the amyloid precursor protein (APP)-cleaving enzyme BACE1 [10] and the neurotrophic factor receptors Trks [11] . SorLA directs trafficking of APP into the recycling pathway [12] . SorCS1 also mediates APP transport [13] . Recent lines of evidence indicate that the altered VPS10P receptor-mediated trafficking could be involved in the pathogenesis of neurodegenerative disorders, including Alzheimer's disease (AD) [12] [13] [14] [15] and frontotemporal lobar degeneration (FTLD) [16] . However, the role of VPS10P receptors in the trafficking of PrP C or PrP Sc and in the pathogenesis of prion disease is little known.
In the present study, we show that sortilin has an inhibitory role in PrP Sc accumulation by 
Results
Sortilin is a novel PrP C -binding protein regulating the surface levels of PrP C To investigate the role of VPS10P cargo receptors in the trafficking of PrP C , we first examined whether or not VPS10P molecules could interact with PrP C . Co-immunoprecipitation assay in neuroblastoma N2aC24 cells showed that SAF61 anti-PrP antibody (Ab) precipitated PrP C with sortilin, but not with other VPS10P molecules ( Fig 1A, S1 Fig) . PrP C was also co-precipitated with sortilin by anti-sortilin Abs (Fig 1B) . GST-pulldown assay using purified recombinant proteins revealed that the VPS10P domain of sortilin fused with GST (GST-VPS10P) successfully pulled down His-tagged full-length recombinant PrP, but not PrP with a deletion of 23-88 residues (Fig 1C) , suggesting that the residues 23-88 are important for PrP C to interact with sortilin. SAF61 anti-PrP Ab also co-precipitated full-length mycHis-tagged sortilin expressed in sortilin-KO N2aC24 cells, designated . Furthermore, co-immunoprecipitation assay using mouse brain homogenates also revealed an interaction between PrP C and sortilin ( Fig 1D) . Immunofluorescence staining of non-permeabilized N2aC24 cells showed co-localization of sortilin and PrP C on the cell surface (Fig 1E and 1F We then knocked down sortilin in N2aC24 cells using two sortilin-specific siRNAs, termed siRNA#1 and #2. Immunostaining of sortilin-knockdown (Sort-KD) cells showed an increase in PrP C expression on the cell surface (Fig 2A) . Biotin labeling of surface proteins confirmed the increased surface levels of PrP C in Sort-KD cells (Fig 2B and 2C) . Total PrP C levels were also increased in Sort-KD cells (Fig 2B and 2C) . However, intracellular PrP C was not increased in Sort-KD cells (Fig 2D) , indicating that the surface PrP C is specifically increased in Sort-KD cells. PrP mRNA levels were not increased in Sort-KD cells (Fig 2E) , suggesting that the increased surface expression of PrP C might be attributable to the impaired degradation of PrP C in Sort-KD cells. PrP C levels were also significantly increased in the brains of sortilin-KO the C-terminal fragment, designated the C1 fragment, being produced [17, 18] . Sort-KD cells [19, 20] .
Sortilin sorts surface PrP C to late endosomes/lysosomes
To address whether or not sortilin could sort surface PrP C to lysosomes for degradation, we first investigated the role of sortilin in internalization of surface PrP C using an Ab-labeling technique. Surface PrP C was labeled with SAF61 anti-PrP Ab at 4˚C in which internalization of membrane proteins is inhibited, and then allowed to be internalized for 2 h at 37˚C. The labeled PrP C was then detected using Alexa Fluoro 488-conjugated anti-mouse IgG Abs. The internalization of the labeled PrP C was slightly but significantly inhibited in Sort-KD cells, compared to that in control N2aC24 cells (Fig 3A and 3B ), suggesting that sortilin could be involved in internalization of some portions of PrP C . To further confirm the involvement of sortilin in internalization of PrP C , we biotinylated the surface proteins of N2aC24 cells and sortilin-KO (ΔSort) cells #1 with sulfo-NHS-SS-biotin, whose biotin motif can be removed by reducing agents. We then allowed the biotinylated proteins to be internalized for 2 h, and treated the cells with the membrane-impermeable reducing agent glutathione to remove the biotins only from surface proteins but not from those internalized. The treated cells were lysed, and then biotin-labeled, internalized proteins were purified using avidin-beads, and investigated for internalized PrP C by Western blotting with 6D11 anti-PrP Ab. Strong signals corresponding to the internalized PrP C were detected in N2aC24 cells (Fig 3C and 3D) . However, the signals were significantly reduced in ΔSort#1 cells (Fig 3C and 3D (Fig 3G and 3H) . Inhibition of lysosomal enzymes by NH 4 Cl increased PrP C markedly in N2aC24 cells, but only slightly in ΔSort#1 cells (Fig 3G and 3H ). PrP C was detected in the LAMP1-positive lysosomes in both cell types after NH 4 Cl treatment (Fig 3I and 3J) . However, its lysosomal localization was much less in ΔSort#1 cells than in N2aC24 cells (Fig 3I and 3J) . These results confirm that transport of PrP C to lysosomes is disturbed in sortilin-deficient cells, therefore reducing the localization of PrP C in lysosomes and resulting in an increase in PrP C levels in sortilin-deficient cells.
We also investigated localization of PrP C in early endosomes in N2aC24 and Sort-KD cells.
PrP C was labeled with SAF61 Ab and spontaneously internalized for 1 h instead of 2 h, which was utilized for detection of internalized PrP C in late endosomes or recycling endosomes, (Fig 4A and 4B) . However, in ΔSort#1 and #2 cells, PrP C in non-raft fractions was reduced to 11.9 and 14.9%, respectively (Fig 4A and 4B) . Instead, PrP C was increased in raft fractions (Fig 4A and 4B) . These results suggest that sortilin could shift the localization of PrP C to non-raft domains from raft domains.
Raft-resident protein flotillin-2 was observed in raft fractions in N2aC24 and ΔSort cells ( Fig  4C) , ruling out the possibility that lack of sortilin could affect the membrane microdomain integrity leading to the shift in the location of surface PrP C in ΔSort cells. Sortilin was predominantly detected in non-raft fractions in N2aC24 and ΔSort cells (Fig 4D) , indicating that We also investigated membrane microdomain location of PrP molecules in prion-infected N2aC24L1-3 cells. In contrast to PrP C detected in raft and non-raft domains in uninfected N2aC24 cells (Fig 4A and 4B ), total PrP molecules and PK-resistant PrP Sc were predominantly detected in raft fractions in prion-infected N2aC24L1-3 cells (S10A and S10B Fig) . These results suggest that prion infection accumulates PrP Sc and PrP C in raft domains.
Sortilin interacts with PrP Sc and facilitates its degradation
We also assessed the role of sortilin in the degradation of PrP Sc . Protein interaction assay using protein-G-conjugated magnetic beads in prion-infected N2aC24L1-3 cells showed that PrP Sc and sortilin were co-collected by anti-sortilin Abs (Fig 5A) 
Prion infection cell-autonomously reduces sortilin after PrP Sc production
We then asked if prion infection could affect sortilin. Interestingly, sortilin was reduced in N2aC24L1-3 cells to 52% of that in N2aC24 cells (Fig 7A and 7B ). However, other VPS10P molecules were not reduced (S12A and S12B Fig) . The reduced levels of sortilin were recovered in cured N2aC24L1-3 cells, which were cured from prion infection after treatment with SAF32 anti-PrP Ab, to that in N2aC24 cells (Fig 7A and 7B ). Sortilin mRNA was similarly expressed between N2aC24 and N2aC24L1-3 cells (S12C Fig) . ScN2a cells, N2a cells persistently infected with RML prions, also expressed sortilin less than N2a cells (S12D and S12E Fig) . Moreover, sortilin was reduced in the brains of terminally ill mice infected with RML and 22L prions to 46.3 and 45.6%, respectively, compared to uninfected mouse brains (Fig 7C and  7D) . These results indicate that prion infection could reduce sortilin. We then treated uninfected N2aC24 and infected N2aC24L1-3 cells with inhibitors to lysosomes (NH 4 Cl and concanamycin A) or proteasomes (MG132). Treatment with NH 4 Cl or concanamycin A increased sortilin in uninfected cells (S13A- S13D Fig) . However, sortilin was much more increased in infected cells after treatment with NH 4 Cl and concanamycin A (S13A-S13D Fig) . In contrast, MG132 did not affect sortilin levels (S13A and S13B Fig) . These results suggest that sortilin could be degraded in lysosomes, and that the lysosomal degradation of sortilin could be stimulated in prion-infected cells.
Fig 5. Sortilin regulates PrP
Sc levels in prion-infected cells. (A) Protein interaction assay using protein-Gconjugated magnetic beads in 22L-infected N2aC24L1-3 cells with rabbit polyclonal anti-sortilin Abs. The immunocomplexes were digested with proteinase K (PK) (100 μg/mL) at 37˚C for 1 h and subjected to Western blotting for PrP We also monitored the levels of sortilin in N2aC24 cells freshly infected with RML prions. There was no significant decrease in sortilin by 3 days post-infection (dpi) while PrP Sc was obviously detectable (Fig 7E and 7F) . Sortilin was decreased at 6 dpi (Fig 7E and 7F) . These results suggest that prion infection reduces sortilin, and that the sortilin reduction is preceded by PrP Sc production. We also performed double immunofluorescence staining for sortilin and PrP Sc in freshly infected N2aC24 cells at 9 dpi. PrP Sc was specifically stained using the mAb132, which was demonstrated to specifically visualize PrP Sc under partially denatured conditions [21] . Since the subcellular positions of sortilin and PrP Sc might differ vertically in infected cells, 6 horizontally serial images at 1 μm interval were used to detect sortilin and PrP
Sc
. In cells displaying green fluorescence for PrP Sc , little or no sortilin (red fluorescence) was detected in any slices (Fig 7G) . In contrast, bright red fluorescence for sortilin was observed only in the cells negative for PrP Sc (Fig 7G) . These results indicate that prion infection could reduce sortilin in a cell-autonomous fashion after PrP Sc accumulation.
Sortilin is known to interact with and transport Trk receptors to the cell surface, thereby enhancing nerve growth factor (NGF) signaling leading to activation of MAP kinases [11] . To investigate whether or not prion infection could affect the function of sortilin, we stimulated uninfected N2aC24 and prion-infected N2aC24L1-3 cells with NGF. Phosphorylated ERK1/2 was increased in N2aC24 and N2aC24L1-3 cells after stimulation (S14A-S14C Fig) . However, the levels of phosphorylated ERK1/2 were significantly lower in N2aC24L1-3 cells than in N2aC24 cells (S14A-S14C Fig) . These results indicate that NGF signaling is impaired in N2aC24L1-3 cells, suggesting that sortilin might be functionally disturbed in prion-infected cells.
Prion disease is aggravated in sortilin-KO mice after infection with prions
We then evaluated the effects of sortilin deficiency on the pathogenesis of prion disease using sortilin-KO (Sort1 -/-) mice. Sort1 -/-mice were viable and fertile and showed no gross abnormalities [11, 22] . Sort1 +/+ (n = 19) and Sort1 -/-female mice (n = 24) were intracerebrally inoculated with RML prions. Incubation and survival times were significantly shortened in Sort1 Table) . Sort1 -/-and Sort1 +/+ mice developed symptoms at 150.9 ± 7.8 and 171.9 ± 6.0 dpi, respectively (Fig 8A, S1 Table) . Western blotting also showed earlier accumulation of PrP Sc in the brains of infected Sort1 -/-mice. PrP Sc was scarcely detectable in the brains of Sort1 +/+ mice at 45 dpi (Fig 8B and 8C ). However, it was obvious in Sort -/-mice at 45 dpi (Fig 8B and 8C) . PrP Sc levels were still significantly higher in Sort1 -/-mice than in Sort1 +/+ mice at 60 and 90 dpi (Fig 8B and 8C) . However, no difference in the levels of PrP Sc was observed between Sort1 +/+ and Sort1 -/-mice at terminal stage (Fig 8B and 8C) . Immunohisto- to that in Sort1 +/+ mice, at 60 dpi (Fig 8D) . However, PrP Sc became indistinguishably accumulated throughout the brains of Sort1 -/-and Sort1 +/+ mice at terminal stage (Fig 8D) . Similar results were also obtained with Sort1 -/-and Sort1 +/+ male mice inoculated with RML prions (S15A-S15D Fig, S2 
PrP
C is a GPI-anchored membrane protein located in raft domains and, to a lesser extent, in non-raft domains. Some of the PrP C molecules internalized are delivered back to the cell surface directly or indirectly via the recycling endosome compartments and others are transported to lysosomes for degradation [7] (Fig 9A) . We showed that sortilin could directly interact with PrP C on the cell surface through the VPS10P domain through the residues 610-753 encompassing cysteine rich 10CCs [23] of sortilin and the N-terminal residues 23-88 of PrP C .
Sortilin-knockdown increased PrP
C on the cell surface and reduced the localization of PrP C to lysosomes, suggesting that the increased surface expression of PrP C in sortilin-knockdown cells might be caused by the decreased trafficking of PrP C to lysosomes for degradation. Sortilin was predominantly located in non-raft domains, and PrP C accumulated at raft domains and decreased in non-raft domains in sortilin-KO cells. It is thus conceivable that sortilin could function to retain PrP C in non-raft domains and be involved in trafficking of non-raft surface PrP C to lysosomes for degradation (Fig 9A) . Low-density lipoprotein receptor-related protein 1 has also been reported as a candidate cargo receptor for the non-raft PrP C [24] . A sortilin-independent pathway may also play a role in PrP C internalization (Fig 9A) . We showed that sortilin deficiency increased PrP C at raft domains and shifted PrP C internalization into the recycling endosomes from lysosomes in cells. It is thus conceivable that the internalization of raft PrP C to the recycling endosomes could be sortilin-independent (Fig 9A) . Taken together, these results suggest that PrP C located in non-raft domains could be internalized to lysosomes for degradation partly via the sortilin-dependent pathway while an internalization pathway to direct PrP C from raft domains to the endocytic recycling pathway could be sortilin-independent (Fig 9A) . [21, 26, 27] . Others are retrogradely transported to the Golgi apparatus where they are subjected to Golgi quality control and trafficked to lysosomes for degradation [28] . Sortilin is expressed on the cell surface and . Sortilin also regulates neuronal cell viability by controlling the release of pro-and maturedform of neurotrophins (NTs), such as NGF and brain-derived neurotrophic factor, as does the transport of their receptors, TrkA, TrkB, and TrkC, to the plasma membrane [9] . No gross abnormalities were reported in Sort1 -/- [11, 22] , probably due to compensatory mechanisms of other family molecules. However, cultured dorsal root ganglion neurons lacking sortilin showed impaired neurite outgrowth upon NGF stimulation [11] . Loss of sortilin also aggravated neurological phenotypes observed in p75 NT receptor (p75 NTR )-KO mice [11] . Sortilin also acts as a co-receptor of p75 NTR against proNTs to transduce cell death signals [30] . We found that sortilin was significantly reduced in prion-infected cells and mouse brains, and that the NGF signaling was disturbed in prion-infected cells. It might thus be interesting to investigate whether or not the sortilin-mediated NT signals are involved in the pathogenesis of prion disease. It remains controversial whether or not degradation of sortilin might be stimulated in lysosomes in other neurodegenerative diseases. Reduced levels of sortilin have been reported in the limbic and occipital regions of AD brains [31] . To the contrary, increased expression of sortilin has been demonstrated in the temporal cortex of AD brains [32] . Other investigators showed no alteration of sortilin levels in the superior frontal and superior temporal cortices of AD brains [33] .
In short, we presented a novel accumulation mechanism of PrP Sc through degradation of sortilin. Prion infection stimulated degradation of sortilin in lysosomes, reducing sortilin levels in prion-infected cells. 
Materials and methods

Ethics statement
All 
Plasmid construction and recombinant proteins
A mouse sortilin cDNA fragment was amplified from mouse brain QUICK-clone cDNA (Clontech, California, USA) by using PCR (primers; 5'-cctctcgagatggagcggccccggggagct-3', 5'-ctcaagcttctattccaggaggtcctcatctga-3') and the amplified fragment was subcloned into pcDNA3.1(-) (Invitrogen) to make an expression vector for full-length sortilin, designated as pcDNA-Sortilin. DNA fragments encoding the VPS10P domain of sortilin, which corresponds to residues 76-750, (primers; 5'-cctctcgagggcgcgcccgccgaggaccaa-3', 5'-ctcaagcttctaggaattctg ctttgtggg-3') were also amplified by PCR using pcDNA-Sortilin as a template and subcloned into pGEX4T-2 (GE healthcare, Little Chalfont, UK) to express glutathione S-transferase (GST)-tagged VPS10P domain of sortilin in E coli. GST-tagged VPS10P domain and GST were induced in E. coli with 0.1 mM isopropyl thiogalactoside at 37˚C for 3 h and purified with glutathione-beads. His-tagged recombinant full-length mouse PrP and PrP without residues 23-88 were prepared as previously described [34] . For construction of an expression vector, termed pEF1-moPrP(3F4), encoding full-length mouse PrP with a 3F4 tag, the BamH I/Xba I-digested fragment of pcDNA3.1-moPrP(3F4) [35] was inserted into BamH I/Xba I-digested pEF1/Myc-His (Invitrogen). To construct an expression vector, pEF1-moPrP(3F4)Δ23-88, encoding 3F4-tagged mouse PrP with residues 23-88 deleted and the 5' fragment of moPrP(3F4)Δ23-88 cDNA was amplified by PCR using pcDNA3.1-moPrP(3F4) as a template with a BamHI-PrP(ATG)-S sense primer (5'-tcggatcccgtcatcatggcgaac-3'; underlined, BamH I site; bold, start codon) and a moPrP(3F4) Δ23-88 anti-sense primer (5'-cctccttggccgcagaggccga-3'; underlined, residues 89-90; italic, residues [19] [20] [21] [22] . Then, full-length moPrP(3F4)Δ23-88 cDNA was amplified by PCR using pcDNA3.1-moPrP(3F4) as a template with the amplified 5' fragment as a sense primer and a PrP(stop)-XbaI-AS anti-sense primer (5'-cctctagagctcatcccacgatcag-3'; underlined, Xba I site; bold, stop codon). After sequence confirmation, the amplified fragment was inserted into BamH I/Xba I-digested pEF1/Myc-His (Invitrogen).
For the construction of a Sortilin-mycHis expression vector, cDNA encoding full-length sortilin was amplified using pcDNA-Sortilin as a template by PCR with a primer pair of Sort-1 (5'-cctctcgagatggagcggccccgggagct-3'; underlined, Xho I site; bold, start codon) and Sort-12 (5'-ctcaagcttttccaggaggtcctcatctga-3'; underlined, Hind III site) and inserted into Xho I/ Hind III digested pcDNA3.1/mycHis(-)A (Invitrogen). Deletion mutants of sortilin were constructed as follows. For construction of sortilinΔ76-177, two DNA fragments with an overlapping DNA segment were amplified using pcDNA-Sortilin as a template by PCR with a primer pair of Sort-1 and Sort-D4 (5'-tatcacctttccgcggcgccaacggccagc-3'; italic, residues 70-75; underlined, residues 178-183) and a primer pair of Sort-D3 (5'-cgttggcgccgcggaaaggtga tactaaca-3'; underlined, residues 72-75; italic, residues 178-183) and Sort-12. These two fragments were hybridized at the overlapping DNA segment and subjected to PCR with a primer pair of Sort-1 and Sort-12, resulting in amplification of a DNA fragment encoding sortilinΔ76-177. The amplified fragment was inserted into Xho I/Hind III digested pcDNA3.1/mycHis(-)A (Invitrogen). Other DNA fragments encoding other sortilin mutants were similarly amplified and inserted into Xho I/Hind III digested pcDNA3.1/mycHis(-)A (Invitrogen). Sort-1 and Sort-D6 (5'-gaaggtttttccagagttctcaggaccaat-3'; italic, residues 172-177; underlined, residues 291-294) and Sort-D5 (5'-cctgagaactctggaaaaaccttcaaaacc-3'; underlined, residues 174-177; italic, residues 291-296) and Sort-12 were used for construction of sortilinΔ178-290. Sort-1 and Sort-D8 (5'-tatatagacccccaagtcggatgttctcca-3'; italic, residues 285-290; underlined, residues 410-413) and Sort-12 and Sort-D7 (5'-acatccgacttggg ggtctatataacaagc-3'; underlined, residues 287-290; italic, residues 410-415) were used for construction of sortilinΔ291-409. Sort-1 and Sort-D10 (5'-ggagtaacccccacggagggaagtcacgtt-3'; italic, residues 404-409; underlined, residues 509-612) and Sort-D9 (5'-acttccctccgtggg ggttactcctgggcg-3'; underlined, residues 406-409; italic, residues 509-514) and Sort-12 were used for construction of sortilinΔ410-508. Sort-1 and Sort-D12 (5'-atcctcttcacaatcatctgagat gtacac-3'; italic, residues 503-508; underlined, residues 610-613) and Sort-D11 (5'-atctcagat gattgtgaagaggatgactat-3'; underlined, residues 505-508; italic, residues 610-615) and Sort-12 were used for construction of sortilinΔ509-609. Sort-1 and Sort-D14 (5'-aatagggacagaattc cgctcaaggatgtc-3'; italic, residues 604-609; underlined, residues 754-757) and Sort-D13 (5'-cttgagcggaattctgtccctattatcctg-3'; underlined, residues 606-609; italic, residues 754-759) and Sort-12 were used for construction of sortilinΔ610-753.
Cell lines and animals
Cells were maintained at 37˚C with 5% CO 2 in air in Dulbecco's Modified Eagle Medium (DMEM, Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (FBS). N2aC24, N2aC24L1-3, and cured N2aC24L1-3 cells were previously established elsewhere [26] . N2aC24 cells were cloned from mouse neuroblastoma N2a cells overexpressing exogenous mouse PrP C . N2aC24L1-3 cells were cloned from N2aC24 cells persistently infected with 22L scrapie prions. Cured N2aC24L1-3 cells are cured from prion infection by treatment with SAF32 antiPrP Ab and then maintained in antibody-free DMEM with 10% FBS. ScN2a cells (kindly gifted from Prof Doh-ura, Tohoku University) were N2a cells persistently infected with RML scrapie prions.
Sortilin-KO cells, ΔSort#1 and #2 cells, were established using the CRISPR-Cas genome editing system. N2aC24 cells were transduced with pRGEN-Cas9-CMV (Takara bio, Shiga, Japan) and pRGEN_Mouse-Sort1_U6_SG_1 targeting the sequence (5'-cctgccgccgtcggccaggaccg-3') (Takara bio), and subjected to limiting dilution cloning. Knockout of sortilin in ΔSort#1 and #2 cells was confirmed by Western blotting.
PrP-KO N2a cells, termed N2aΔPrP cells, were also established using the CRISPR-Cas genome editing system. N2a cells were transduced with pRGEN-Cas9-CMV (Takara bio) and pRGEN_PrP_U6_SG_1 targeting the sequence (5'-accggtggaagccggtatcccgg-3') (Takara bio), and subjected to limiting dilution cloning. Knockout of PrP C in N2aΔPrP cells was con- ) mice used in this study were previously produced elsewhere [11, 22] . Sort1 -/-mice having been backcrossed for 10 generations into C57BL/6 were intercrossed with C57BL/6 mice (Charles River Laboratories, Kanagawa, Japan), and the resulting heterozygous mice (Sort -/+ ) were then intercrossed to obtain Sort -/-and wild-type (Sort +/+ ) mice.
Immunoprecipitation
Cells were lysed in buffer A [20 mM MES-KOH (pH 7.0), 0.15 M KCl, 1 mM DTT, 10% glycerol, 0.2% (w/v) CHAPS] containing protease inhibitor cocktail (Nakalai tesque, Kyoto, Japan). The lysate was cleared by centrifugation for 5 min at 20,000×g at 4˚C and the supernatant was transferred to a new tube. 500 μL of supernatant containing 500 μg of total proteins were incubated with 1 μg of indicated Abs for 2 h. 5 μL of protein-G sepharose (GE healthcare) was added and the mixture was rotated for 4 h at 4˚C. Thereafter, protein-G sepharose was precipitated and the precipitant was washed with buffer A 5 times. The final precipitate with protein-G sepharose was suspended in 50 μL of Laemmli's sample buffer, heated, and subjected to Western blotting to detect proteins of interest with appropriate Abs.
Protein interaction assay using Dynabeads protein-G
For detection of interaction of PrP Sc and sortilin, 15 μL of Dynabeads protein-G (Thermo Fisher Scientific) was added instead of protein-G sepharose. Immunocomplexes were collected using magnet instead of centrifugation and washed with buffer A. The same procedure was repeated 5 times. The finally collected complexes were suspended in 45 μL of buffer B [150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 0.5% (w/v) Triton X-100, 0.5% (w/v) sodium deoxycholate, 1 mM EDTA] containing 100 μg/ml proteinase K (PK) and incubated at 37˚C for 60 min with mixing at 1,100 rpm using Thermomixer (Eppendorf, Hamburg, Germany). The PK-treated samples were denatured in Laemmli's sample buffer and subjected to Western blotting to detect PrP After washing the cells with ice-cold-PBS, they were suspended in 1 mL of buffer C. To homogenize the cells, the cell suspension was passed through a 27G needle 10 times. The homogenate was centrifuged at 500×g for 10 min at 4˚C and the supernatant was incubated with 15 μL of Dynabeads protein-G with gentle agitation for 2 h at 4˚C. The beads were collected by magnet and washed with buffer C. The collected immunocomplexes on the beads were washed with buffer A 5 times and finally suspended in 50 μL of Laemmli's sample buffer and subjected to Western blotting.
GST pulldown assay
2 μg of GST-tagged VPS10P domain of sortilin, which was pre-bound to 5 μL of glutathione beads, was incubated with 2 μg of His-tagged full-length recombinant PrP or His-tagged recombinant PrP lacking residues 23-88 in buffer A containing protease inhibitor cocktail for 2 h with rotation at 4˚C. The precipitate was washed with buffer A 5 times, suspended in Laemmli's sample buffer, heated, and subjected to Western blotting. GST-tagged VPS10P domain and His-tagged PrPs were detected with rabbit polyclonal anti-sortilin Abs and RGS-His Ab, respectively.
Biotinylation of cell surface proteins
Biotinylation of cell surface proteins was carried out as described elsewhere [26] . In brief, cells (85-95% confluent) were washed with PBS and incubated with Sulfo-NHS-LC Biotin (Thermo Fisher Scientific) in PBS for 30 min at room temperature. The cells were then washed with 0.1 M glycine in PBS and lysed in buffer B. The lysate was mixed with NeutrAvidin UltraLink Resin (Thermo Fisher Scientific) for 4 h at 4˚C and the biotinylated protein-resin complexes were collected by brief microcentrifugation. The complexes were then washed with the buffer and heated at 99˚C for 10 min in Laemmli's sample buffer to separate the biotinylated proteins from the complexes. The biotinylated proteins in the supernatant were subjected to Western blotting.
Immunofluorescence staining
Cells were stained with indicated Abs as described previously [26] . In brief, cells grown on coverslips were fixed in 3% paraformaldehyde (PF) for 15min and treated with 0.1 M glycine in PBS for 10 min. Permeabilization was carried out using 0.1% Triton X-100 in PBS for 4 min at RT. To detect PrP Sc , the cells were treated with 5 M guanidinium thiocyanate for 10 min at RT. After washing with PBS, the cells were incubated with the first Ab in 5% FBS in PBS and then with fluorescent secondary Ab. For detection of PrP Sc , mouse anti-PrP Ab clone 132 [21] (kindly gifted from Prof Horiuchi, Hokkaido University) was used as a first Ab. After washing, the coverslips were mounted with Prolong Gold antifade reagent (Invitrogen). Fluorescence images were obtained using BIOREVO BZ-9000 (Keyence, Osaka, Japan), which is equipped with haze reduction function, which enables production of fluorescent images very similar to those taken by a confocal microscope. To assess the co-localization of proteins of interest, Pearson's correlation coefficient was calculated using Co-localization Plugin (JaCoP) tool in Image J [36] .
Internalization assay of antibody-labeled surface PrP
Cells were washed with ice-cold PBS and treated with 1% BSA in PBS for 10 min at 4˚C prior to incubation with the indicated anti-PrP Abs (1 μg/mL) for 10 min at 4˚C in 1% BSA-containing PBS. The cells were then washed with ice-cold PBS and incubated at 37˚C for 2 h. Thereafter, the cells were fixed with 3% paraformaldehyde, permeabilized with 0.1% Triton X-100, and stained with Alexa Fluoro 488 anti-mouse IgG Ab (Thermo Fisher Scientific). Fluorescent signals were observed using BIOREVO BZ-9000 (Keyence) and their intensities were analyzed using BZ-II analyzer (Keyence).
Internalization assay of biotinylated surface PrP
Cells were washed three times with ice-cold PBS (pH7.4) and incubated with 5 mg/mL sulfo-NHS-SS-biotin (Thermo Fisher Scientific) in PBS (pH 7.4) at 4˚C for 10 min to biotinylate cell surface proteins. After washing the cells twice with ice-cold PBS (pH 7.4) and incubation with 50 mM glycine in PBS (pH 7.4), the cells were further washed twice with ice-cold PBS (pH 7.4). Thereafter, the cells were incubated in DMEM medium at 37˚C. After 2 h-incubation, the cells were washed three times with ice-cold PBS (pH 7.4), and biotin was removed from the proteins still on the cell surface by incubating the cells with 100 mM reducing glutathione in PBS (pH 7.4) at 37˚C for 10 min. After washing the cells with ice-cold PBS (pH 7.4), the cells were lysed in buffer B containing protease inhibitor cocktail (Nakalai tesque). The lysate was cleared by centrifugation for 5 min at 20,000×g at 4˚C and the supernatant was transferred to a new tube. 20 mL of NeutrAvidin beads (Thermo Fisher Scientific) was added into the cell lysate containing 300 mg of proteins and the mixture was rotating at 4˚C for 2 h. After washing the beads with lysis buffer, the beads was suspended in 50 mL of SDS-PAGE sample buffer and subjected to Western blotting with 6D11 anti-PrP Ab. 
RT-PCR
Total RNA was extracted using an RNeasy Mini Kit (QIAGEN, Hilden, Germany) and firststrand cDNA was synthesized using SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen). The synthesized cDNAs were amplified with the following primer sets: 5'-aagcag gactcccgcccacag-3' and 5'-ttccaggaggtcctcatctga-3' for sortilin cDNA, 5'-tacagcaaccagaacaac-3' and 5'-tcatcccacgatcaggaagat-3' for PrP cDNA, and 5'-cctgccaagtatgatgacatc-3' and 5'-gctgtag ccgtattcattgtc-3' for glyceraldehyde-3-phosphate dehydrogenase cDNA.
Fractionation of membrane microdomains
Cells grown to~80% confluency in a 35 mm tissue culture dish were suspended in 250 μL of MBS buffer [25 mM MES-NaOH (pH 6.5), 0.15 M NaCl] containing 1% (w/v) Triton X-100, and homogenized by being passed through a 21G-needle 15 times. After centrifugation at 500×g for 5 min at 4˚C, 220 μL of the supernatant was transferred to a new tube and mixed with 220 μL of MBS buffer containing 80% (w/v) sucrose to make 40% (w/v) sucrose. 200 μL of the sample was placed at the bottom of a discontinuous sucrose gradient consisting of 600 μL of 30% (w/v) sucrose and 200 μL of 5% (w/v) sucrose. The sample was centrifuged at 140,000×g for 24 h at 4˚C in an S55S rotor (Hitachi Koki, Tokyo, Japan). Ten fractions (100 μL/fraction) were collected from the top.
Prion infection
Brains were removed from terminally ill wild-type C57BL/6 mice infected with RML prions. A single brain was homogenized (10%, w/v) in PBS using a multi-beads shocker (Yasui Kikai, Osaka, Japan) and then diluted to 1% with PBS. Two 1% (w/v) brain homogenates were mixed to prepare the homogenate of 2 pooled brains and the resulting homogenate was intracerebrally inoculated into a 4-5 week-old mouse with its 20 μL aliquot. The signs for diseaserelated symptoms were evaluated as previously described [37] .
For infection of cells, cells were seeded at a density of 2×10 5 cells/well in a 6-well tissue culture plate. At 4 h after cell seeding, the clarified RML-infected brain homogenate [34] containing 50 μg proteins was added to the well and cells were subsequently passaged every 3 days.
Immunohistochemistry
Paraffin-embedded samples were sectioned, deparaffinized, and rehydrated. The samples were autoclaved in 1 mM HCl at 121˚C for 5 min and subsequently washed with PBS. The samples were then digested with 50 μg/mL PK in PBS at 37˚C for 30 min, treated with 3 M guanidine thiocyanate for 10 min, and washed with PBS. After blocking with 5% FBS in PBS for 1 h, the sampled were incubated with 6D11 anti-PrP Ab for 2 h, washed with PBS, and treated with ImmPRESS REAGENT Anti-Mouse IgG (Vector Laboratories, U.S.A) for 30 min. After washing with PBS, the samples were incubated with ImmPACT DAB (Vector Laboratories) for 180 sec for staining.
Western blotting
Western blotting was performed as reported previously [26] . To evaluate protein expression, signals were densitometrically measured using LAS-4000 mini (Fujifilm Co., Tokyo, Japan). The measured intensity of target proteins was normalized against the signal intensity of β-actin used as an internal control protein.
NGF stimulation
Cells were removed from a tissue culture dish by pipetting and transferred to a new tube. After washing with DMEM medium, cells were collected by centrifugation at 500×g for 2 min at 4˚C, suspended in 1 mL of DMEM medium containing 2 nM NGF (Thermo Fisher Scientific), transferred into a well of 12 well plate, and incubated for 10 min at 37˚C in a 5% CO 2 incubator. The cells were collected by centrifugation at 500×g for 5 min at 4˚C and washed with icecold PBS. The pellet was lysed in 200 μL of buffer B containing protease inhibitor cocktail (Nakalai tesque). The lysate was cleared by centrifugation at 12,000×g for 2 min at 4˚C and the supernatant was subjected to Western blotting.
Isolation of exosomes
Cells were cultured in 2 mL of DMEM medium containing 10% exosome-depleted FBS (System Bioscience, CA,USA) in a 6 well tissue culture plate for 72 h and the culture medium was collected. The culture medium was centrifuged at 2,000×g for 10 min at 4˚C. The supernatant was passed through 0.22 μm pore filter membrane and the flow-through was centrifuged at 10,000×g for 30 min at 4˚C. Exosomes in the supernatant were collected by ultracentrifugation at 100,000×g for 1 h at 4˚C and washed with PBS. The exosomes were dissolved in 100 μL of Laemmli's sample buffer and subjected to Western blotting.
Detection of the C1 fragment
Cell lysate containing 20 μg proteins was incubated in 20 μL of (1×) glycoprotein denaturing buffer (0.5% SDS, 40mM DTT) at 99˚C for 10 min. Thereafter, 3μl of 10% NP-40, 3 μL of (10×) Glycobuffer, 3.5 μl of distilled water and 0.5 μL of PNGase (500 units/μl) (New England BioLabs, MA, USA) were added. After 60 min incubation at 37˚C, samples were mixed with 10 μL of (4×) Laemmli's sample buffer and subjected to Western blotting.
Statistical analysis
Survival and incubation times are analyzed using the log-rank test. Other data were analyzed using the one-way ANOVA.
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